InsidersTradesSigma
Discover the full insider trade history of Scinai Immunotherapeutics Ltd., a listed issuer based in United States. Shares are listed on US US, under the authority of SEC (Form 4). The latest transaction was filed on 18 June 2026 (Attribution). Among the most active insiders: GERMAIN MARK. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Scinai Immunotherapeutics Ltd. is a company focused on developing immunotherapeutic treatments. It is listed on NASDAQ.